Clinical education library
Browse our library of clinical education, offering insights into diabetes pathophysiology and treatment, practice management and patient care. All are ready to watch, download or share with your colleagues.
Filter
PDF
Summary of ADA Treatment Recommendations for Type 2 Diabetes
A summary algorithm that includes an ADA-recommended overall approach for glucose-lowering medication in type 2 diabetes.
Diabetes Cardiovascular Outcomes Trials (CVOTs): What You Need to Know
Dr. Michael Davidson reviews the history and key design elements of the diabetes CVOT, statistical tools used to interpret CVOT data and guidance on putting the data into context.
What is the Burden of Type 2 Diabetes and Related Complications?
Dr. Doron Schneider explores the increasing burden of type 2 diabetes, including the economic impact of improved assessment, the management of patients with T2D and factors that may impact patient management.
PDF
The Impact of COVID-19 on Patients with Type 2 Diabetes
Data from two studies highlight how COVID-19 has illuminated the critical importance of glycemic control in type 2 diabetes.
Exploring a Population Health Management (PHM) Approach: A Health System Perspective
In part 3 of the 5-part PHM series, Dr. Bradley Eilerman discusses the steps to successful PHM implementation, the value of the comprehensive care team and the impact of collected patient data.
Exploring a Population Health Management (PHM) Approach: Approach of an ACO
In part 5 of the 5-part PHM series, Dr. Michael Soboiero discusses how PHM has impacted diabetes management within his accountable care organization (ACO), advanced patient care strategies and improved quality care measures.
PDF
Medicare Part D and Your Patients
Information to help facilitate discussions with your patients about Medicare prescription drug costs, with details on why coverage is changing and extra ways they may be able to get financial help.
PDF
Time in Range Consensus Statement Summary Card
Reference card summarizing recommendations from the International Consensus on time in range and glucose variability. A sample Ambulatory Glucose Profile (AGP) is included.
website
Type 2 Diabetes and Cardiovascular Disease: Custom In-Office Materials
Educational materials you can customize, display and share with patients to help them make the connection between type 2 diabetes and cardiovascular disease.
PDF
2020 Expert Consensus Decision Pathway Booklet
Brochure summarizing the American College of Cardiology's Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes.
COVID-19 and Diabetes, What You Need to Know
23:33
COVID-19 and Diabetes, What You Need to Know
Join experts in type 2 diabetes (T2D): Dr. John Anderson (primary care provider), Dr. Eden Miller (primary care provider), and Dr. Serge Jabbour (endocrinologist) for an in-depth discussion on how COVID-19 impacts patients with T2D and what you can do to help your patients as new information is discovered during this evolving landscape.
The Burden of T2D
18:45
The Burden of T2D
Join experts in type 2 diabetes (T2D): Dr. John Anderson (primary care provider), Dr. Susan Cornell (clinical pharmacist and certified diabetes care and education specialist) and Dr. Doron Schneider (primary care provider) as we discuss the enormous physical, emotional, psychological and economic burden of T2D and its comorbidities on the US healthcare system and on our patients and what we, as clinicians need to do to ease this burden.
Beta-Cell Dysfunction: A Driver of T2D?
11:27
Beta-Cell Dysfunction: A Driver of T2D?
Join primary care experts in type 2 diabetes (T2D): Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis, what clinicians know or should know about it and how it is measured in the clinic, and how our current knowledge of beta-cell function in T2D may affect future research on T2D treatment.
The Role of Endogenous GLP-1
15:29
The Role of Endogenous GLP-1
Join multidisciplinary experts in type 2 diabetes (T2D): Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D.
Understanding the Role of Insufficient GLP-1 Activity in T2D
9:15
Understanding the Role of Insufficient GLP-1 Activity in T2D
Join experts in type 2 diabetes (T2D): Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.
Should We Be Thinking Differently About Type 2 Diabetes?
23:13
Should We Be Thinking Differently About Type 2 Diabetes?
Join experts in type 2 diabetes (T2D): Dr John Anderson (primary care provider), Ms Lucia Novak (Nurse Practitioner), and Dr Joshua Stolker (cardiologist) as they talk about ways to think differently about type 2 diabetes and consider factors in addition to A1C such as comorbidities, recommendations on managing patients with T2D from national endocrinology and cardiology societies, and how the cardiology community can work with the diabetology community to provide the best care for patients with T2D.
T2D and Cardiovascular Disease
15:53
T2D and Cardiovascular Disease
Join experts: Dr John Anderson (primary care physician), Dr Pam Taub (cardiologist), and Dr Mark Greathouse (cardiologist) as they review the relationship between type 2 diabetes (T2D) and cardiovascular disease (CVD), including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD.